March 19th, 2023Advamedica Inc announces FDA clearance for Ax-Surgi Surgical Hemostat
Cambridge, Massachusetts: Advamedica Inc., a biomaterial focused medtech startup today announced the US Food and Drug Administration (FDA) 510(k) clearance for its latest innovation, Ax-Surgi Surgical Hemostat. With this, Ax-surgi has become first and only...
July 1st, 2021Advamedica Inc., a biomaterial focused medtech startup has announced FDA 510(k) clearance of its hemostatic product, Axiostat Patch that helps control moderate to severe bleeding in vascular procedures, surgical debridement sites, puncture sites and more.
Clearance granted several months ahead of the initial schedule
Launch in the...
February 5th, 2021Integrated woundcare company, Axio Biosolutions today announced that it has received European CE Certification from DNV GL Norway for its next generation advanced wound care product range, MaxioCel. The regulatory approval paves the path for Axio to tap into a fast growing $15 billion advanced woundcare market, globally.
This...
February 28th, 2018
Axiostat has become the first Indian wound care product to receive 510(K) FDA clearance in the US for its external hemostatic dressing. Axiostat, a 100% chitosan haemostatic dressing to stop external bleeding, was earlier approved with CE mark in Europe. The FDA clearance now allows Axiostat to be marketed in the US as over-the-counter...
November 8th, 2017Medtech startup Axio Biosolutions reports successful results from clinical trial of Axiostat Dental Haemostatic Dressing in Patients on Oral Antiplatelet Drugs
Bangalore: Nov 08 2017:
Axio Biosolutions, developer of novel 100% chitosan haemostat reported that its Axiostat Dental Haemostatic Dressing was found to be more than 10...
